BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
CDC vaccine panel votes to remove universal hepatitis B birth dose recommendation - 2Robyn returns to music with 'Dopamine,' her 1st single in 7 years: 'Came to save music once again'
- 3Islamabad: Iran allows 20 Pakistani ships through Strait of Hormuz
- 46 Well known Nissan Vehicles in the U.S.
- 5Figure out How to Alter Your Volvo XC40 for Further developed Solace
- Watch Blue Origin's huge New Glenn rocket ace its epic landing on a ship at sea (video)
- Warship sunk by British fleet, remains of sailor found after 225 years
- 5 Arising Professions in Environmentally friendly power
- What to know about King Charles III's cancer treatment and his message to the public
- Merz says army could be involved in mine-clearing from Hormuz
- Artemis II's moon-bound astronauts capture Earth's brilliant blue beauty as they leave it behind
- Vial marked 'Polonium 210' sparks scare during German Easter egg hunt
- Artemis II's moonbound toilet is working again to astronauts' relief after overnight fix
- Photos: Presidential turkey pardons — a look back
